Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population
Jean-David Morel, … , Shannon Mullican, Johan Auwerx
Jean-David Morel, … , Shannon Mullican, Johan Auwerx
Published February 8, 2023
Citation Information: JCI Insight. 2023;8(3):e164626. https://doi.org/10.1172/jci.insight.164626.
View: Text | PDF
Research Article Nephrology

Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population

  • Text
  • PDF
Abstract

Acute kidney failure and chronic kidney disease are global health issues steadily rising in incidence and prevalence. Animal models on a single genetic background have so far failed to recapitulate the clinical presentation of human nephropathies. Here, we used a simple model of folic acid–induced kidney injury in 7 highly diverse mouse strains. We measured plasma and urine parameters, as well as renal histopathology and mRNA expression data, at 1, 2, and 6 weeks after injury, covering the early recovery and long-term remission. We observed an extensive strain-specific response ranging from complete resistance of the CAST/EiJ to high sensitivity of the C57BL/6J, DBA/2J, and PWK/PhJ strains. In susceptible strains, the severe early kidney injury was accompanied by the induction of mitochondrial stress response (MSR) genes and the attenuation of NAD+ synthesis pathways. This is associated with delayed healing and a prolonged inflammatory and adaptive immune response 6 weeks after insult, heralding a transition to chronic kidney disease. Through a thorough comparison of the transcriptomic response in mouse and human disease, we show that critical metabolic gene alterations were shared across species, and we highlight the PWK/PhJ strain as an emergent model of transition from acute kidney injury to chronic disease.

Authors

Jean-David Morel, Maroun Bou Sleiman, Terytty Yang Li, Giacomo von Alvensleben, Alexis M. Bachmann, Dina Hofer, Ellen Broeckx, Jing Ying Ma, Vinicius Carreira, Tao Chen, Nabil Azhar, Romer A. Gonzalez-Villalobos, Matthew Breyer, Dermot Reilly, Shannon Mullican, Johan Auwerx

×

Figure 2

Strain-specific histological changes in the kidney upon folic acid injury.

Options: View larger image (or click on image) Download as PowerPoint
Strain-specific histological changes in the kidney upon folic acid injur...
Histology slides were scored by pathologist in a double-blind manner. (A) Representative images of severity grade 1–4 kidney tubule dilation, tubule degeneration, interstitial inflammation, and fibrosis. Strains and time points are indicated on the left, and severity grades are indicated on the right. (B) Heatmap of the severity grades of kidney histology in each strain and time point. Statistical significance is shown representing Wilcoxon test comparison between FA and control, using FDR-corrected P values (***P < 0.001, **P < 0.01,*P < 0.05).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts